About this episode
his Week in Review covers 5 episodes from October 06 to October 10, featuring major developments in the pharmaceutical and biotech industries.
Episodes included:
1. Pharma and Biotech Daily: Novo's Acquisition, FDA Breakthroughs, and Industry Updates
2. Pharma and Biotech Daily: Top Stories in the Industry from Zenas to Lilly
3. Pharma and Biotech Daily: Tariff Impact, Promising Trials, and Industry Leaders
4. Pharma and Biotech Daily: The Latest in Cell and Gene Therapy, M&A Activity, and Regulatory Updates
5. The Essential Updates in Pharma and Biotech: Your Daily Dose of What Matters
Key topics covered:
- Strategic acquisitions and partnerships
- Regulatory updates and FDA approvals
- Clinical trial results and breakthroughs- Industry trends and market developments
Stay informed with Pharma Daily's comprehensive coverage of the pharmaceutical and biotech world
Get every episode summarized
Each time Pharma and BioTech Daily publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Pharma and BioTech Daily
Moderna's $1B mRNA Cancer Vaccine Boosts Personalized Meds | Pharma and Biotech...
Pharma and BioTech Daily
FDA Expands Bayer's Hyrnuo Approval | Pharma and Biotech Daily
Pharma and BioTech Daily
Sandoz Invests $2.5B in Biosimilars Network | Pharma and Biotech Daily
Pharma and BioTech Daily
AstraZeneca's $116M FDA Win: New Breast Cancer Drug | Pharma and Biotech Daily
Pharma and BioTech Daily